ArticleEfficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 DiabetesAuthor:Aaron Larson, PharmD, BCPSPublish date: October 30, 2025Type 2 diabetes mellitus (T2DM) is a chronic disease becoming more prevalent each year and is the seventh-leading cause of death in the United Stat...Read More
